250 related articles for article (PubMed ID: 29245183)
1. Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis.
Fleury M; Belkina AC; Proctor EA; Zammitti C; Simms RW; Lauffenburger DA; Snyder-Cappione JE; Lafyatis R; Dooms H
Arthritis Rheumatol; 2018 Apr; 70(4):566-577. PubMed ID: 29245183
[TBL] [Abstract][Full Text] [Related]
2. Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.
Lavon I; Heli C; Brill L; Charbit H; Vaknin-Dembinsky A
Front Immunol; 2019; 10():835. PubMed ID: 31134049
[No Abstract] [Full Text] [Related]
3. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.
Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D
Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
[TBL] [Abstract][Full Text] [Related]
6. PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma.
Zelba H; Bedke J; Hennenlotter J; Mostböck S; Zettl M; Zichner T; Chandran A; Stenzl A; Rammensee HG; Gouttefangeas C
Cancer Immunol Res; 2019 Nov; 7(11):1891-1899. PubMed ID: 31484656
[TBL] [Abstract][Full Text] [Related]
7. TIGIT expression is upregulated in T cells and causes T cell dysfunction independent of PD-1 and Tim-3 in adult B lineage acute lymphoblastic leukemia.
Zhang X; Zhang H; Chen L; Feng Z; Gao L; Li Q
Cell Immunol; 2019 Oct; 344():103958. PubMed ID: 31376919
[TBL] [Abstract][Full Text] [Related]
8. Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade.
Grabmeier-Pfistershammer K; Stecher C; Zettl M; Rosskopf S; Rieger A; Zlabinger GJ; Steinberger P
Clin Immunol; 2017 Oct; 183():167-173. PubMed ID: 28882621
[TBL] [Abstract][Full Text] [Related]
9. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
[TBL] [Abstract][Full Text] [Related]
10. Correlations of the expression of γδ T cells and their co-stimulatory molecules TIGIT, PD-1, ICOS and BTLA with PR and PIBF in the peripheral blood and decidual tissues of women with unexplained recurrent spontaneous abortion.
Liang Q; Tong L; Xiang L; Shen S; Pan C; Liu C; Zhang H
Clin Exp Immunol; 2021 Jan; 203(1):55-65. PubMed ID: 33017473
[TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoint Receptors Tim-3 and PD-1 Regulate Monocyte and T Lymphocyte Function in Septic Patients.
Xia Q; Wei L; Zhang Y; Sheng J; Wu W; Zhang Y
Mediators Inflamm; 2018; 2018():1632902. PubMed ID: 30595665
[TBL] [Abstract][Full Text] [Related]
12. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.
Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M
J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface.
Wang S; Zhu X; Xu Y; Zhang D; Li Y; Tao Y; Piao H; Li D; Du M
Hum Reprod; 2016 Apr; 31(4):700-11. PubMed ID: 26908841
[TBL] [Abstract][Full Text] [Related]
14. High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
Mollavelioglu B; Cetin Aktas E; Cabioglu N; Abbasov A; Onder S; Emiroglu S; Tükenmez M; Muslumanoglu M; Igci A; Deniz G; Ozmen V
World J Surg Oncol; 2022 Oct; 20(1):349. PubMed ID: 36271406
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis.
Fukasawa T; Yoshizaki A; Ebata S; Nakamura K; Saigusa R; Miura S; Yamashita T; Hirabayashi M; Ichimura Y; Taniguchi T; Asano Y; Shimizu H; Kazoe Y; Mawatari K; Kitamori T; Sato S
Arthritis Rheumatol; 2017 Sep; 69(9):1879-1890. PubMed ID: 28556548
[TBL] [Abstract][Full Text] [Related]
16. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
[TBL] [Abstract][Full Text] [Related]
17. Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis.
Yu Y; Chen Z; Wang Y; Li Y; Lu J; Cui L; Yu Z; Ding Y; Guo C; Zhang X; Shi Y
Int Immunopharmacol; 2021 Jul; 96():107722. PubMed ID: 33965878
[TBL] [Abstract][Full Text] [Related]
18. Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis.
Varghese JF; Kaskow BJ; von Glehn F; Case J; Li Z; Julé AM; Berdan E; Ho Sui SJ; Hu Y; Krishnan R; Chitnis T; Kuchroo VK; Weiner HL; Baecher-Allan CM
Front Immunol; 2024; 15():1360219. PubMed ID: 38745667
[TBL] [Abstract][Full Text] [Related]
19. Increased exhausted CD8
Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
[TBL] [Abstract][Full Text] [Related]
20. Tim-3 signaling blockade with α-lactose induces compensatory TIGIT expression in Plasmodium berghei ANKA-infected mice.
Zhang Y; Jiang N; Zhang T; Chen R; Feng Y; Sang X; Yang N; Chen Q
Parasit Vectors; 2019 Nov; 12(1):534. PubMed ID: 31711531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
